pharmaphorum

FEBRUARY 4, 2021

A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month. The book features insights and recommendations from 40 leading experts in the field, who hope that Italy will begin to follow in the footsteps of early adopters of digital therapeutics such as Germany, France and

Documentation 139

Documentation Communication 139

Pharma Times

FEBRUARY 3, 2021

The data show 100% protection against severe disease, hospitalisation and death, greater vaccine efficacy with an inter-dose interval of 12 weeks or more, and the potential for reduced asymptomatic transmission

Vaccines 122

Vaccines 122

Outsourcing Pharma

FEBRUARY 15, 2021

A new trial for the AstraZeneca/Oxford COVID-19 vaccine will investigate the efficacy of the vaccine in children aged six and over.

Vaccines 144

Vaccines 144

NY Times

FEBRUARY 3, 2021

The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.

124

124

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Patent Watch

FEBRUARY 11, 2021

Are you tired of having to naviagate complicated contracts to access the information you need? Let DrugPatentWatch free you from weeks of negotiating complex contracts and let you focus on…. The post Say ‘NO’ to bad contracts appeared first on DrugPatentWatch - Make Better Decisions.

109

109

Pharma Marketing Network

FEBRUARY 16, 2021

It’s 2019, your plane is booked, your outfits for the next three days are all planned out and packed away in your suitcase. You have a list of all of the presentations you plan on attending during the three-day pharmaceutical conference in New Orleans, and all of your lines have been practiced in front of a mirror for when you go to interview some of the keynote speakers.

Communication 98

Communication 98

Pharma Times

FEBRUARY 10, 2021

Trial is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID)

151

151

Outsourcing Pharma

FEBRUARY 4, 2021

The founder of Andaman7âs leukemia diagnosis, and his sonâs experience with bone cancer, have helped inform the firm's tech and patient-centric approach.

131

131

NY Times

FEBRUARY 28, 2021

The company’s coming trials will also involve pregnant women and people whose immune systems are compromised.

Immunity 144

Immunity Immunization Vaccines 144

Drug Patent Watch

FEBRUARY 2, 2021

DrugPatentWatch was featured in a recent article by Inc. Magazine. In their coverage of Mark Cuban’s new pharma company, they cited our published interview where Mark Cuban Sounds off on Drug Prices.…. The post DrugPatentWatch featured in Inc Magazine appeared first on DrugPatentWatch - Make Better Decisions.

Drug Pricing 103

Drug Pricing 103

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Marketing Network

FEBRUARY 4, 2021

Moderator and Panelists: Amy Turnquist , EVP, Digital, eHealthcare Solutions (Moderator). Ryan Billings , U.S. Oncology Digital Marketing & Customer Experience at GSK. Desiree Priestley , Director, Patient Support Strategy & Insights at Otsuka America Pharmaceutical. Kristen Palmer Winters , Customer Experience (CX), Americas Hub, Digital & Commercial Innovation, Bayer.

98

98

pharmaphorum

FEBRUARY 5, 2021

Over the last year, we’ve noticed that “connectivity” doesn’t always equate to “connected” – and that’s just as true in the realm of clinical trials as it is in our personal lives. Amanda Barrell reports from a panel at the Patients as Partners Europe conference on remote clinical trials. Decentralised trials have been growing in popularity in recent years, and the COVID-19 pandemic has served to accelerate that progress.

Hospitals 132

Hospitals Communication 132

Pharma Times

FEBRUARY 8, 2021

Jazz will add GW's plant-derived cannabinoid treatment Epidiolex to its roster

158

158

Outsourcing Pharma

FEBRUARY 15, 2021

With pharma firms seeking solutions to get products in the hands of patients faster, one company believes blockchain technology could provide answers.

Drug Development 116

Drug Development 116

NY Times

FEBRUARY 10, 2021

In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average.

Diabetes 132

Diabetes 132

Drug Patent Watch

FEBRUARY 3, 2021

This article was originally published by Ioana Gherghescu and Begoña Delgado-Charro in Pharmaceutics 2021, 13(1) under a Creative Commons Attribution License. Abstract Biosimilar medicines expand the biotherapeutic market and improve…. The post The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA appeared first on DrugPatentWatch - Make Better Decisions.

Biosimilars 98

Biosimilars 98

Eye on FDA

FEBRUARY 10, 2021

Last month we looked at a review of FDA press releases for last year and as one might have expected, there was an enormous spike in communications as a result of the COVID-19 pandemic. Looking now to a review of enforcement by the Office of Prescription Drug Promotion (OPDP) in 2020, we see a different picture. We instead see the same pace as we have the past several years – that is anemic levels of enforcement.

Communication 77

Communication Biosimilars Compounding 77

pharmaphorum

FEBRUARY 11, 2021

Shares in Swiss biotech AC Immune have risen sharply after it said a vaccine in development for Alzheimer’s disease (AD) hit the mark in a phase 1/2 trial. . ACI-35.030, partnered with Johnson & Johnson, is designed to stimulate the body to generate antibodies against tau protein, one of the factors though to play a role in the development of AD dementia.

Immunity 127

Immunity Immunization Vaccines 127

Pharma Times

FEBRUARY 9, 2021

Charity has urged the UK government to provide clarity on whether people receiving antibiotics can receive a COVID-19 vaccination

Vaccines 123

Vaccines 123

Outsourcing Pharma

FEBRUARY 16, 2021

A study by two trial technology firms reportedly indicates that decentralized trials are outperforming on-site in recruitment, retention and other aspects.

105

105

NY Times

FEBRUARY 7, 2021

Officials are racing to vaccinate as many people as possible in order to outpace more contagious variants of the virus that were first identified in Britain and South Africa.

Vaccines 99

Vaccines Immunity Immunization 99

Drug Patent Watch

FEBRUARY 25, 2021

Annual Drug Patent Expirations for JORNAY+PM Jornay Pm is a drug marketed by Ironshore Pharms and is included in one NDA. There are eleven patents protecting this drug. JORNAY PM…. The post New patent for Ironshore Pharms drug JORNAY PM appeared first on DrugPatentWatch - Make Better Decisions.

81

81

pharmaphorum

FEBRUARY 17, 2021

John Singer discusses the disbanding of Haven, the joint healthcare venture by Amazon, JP Morgan and Berkshire Hathaway, and the strategies that can help fix US healthcare. . “The market” was terrified when Warren Buffett, Jamie Dimon and Jeff Bezos got together to disrupt healthcare three years ago with the launch of Haven – in response to that news, healthcare stocks comprising a significant chunk of the $3.5 trillion health economy in the United States shed billions in value overnight.

Online Pharmacies 124

Online Pharmacies Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 124

pharmaphorum

FEBRUARY 1, 2021

It’s well recognised that people with psoriasis can develop depression or anxiety, particularly in moderate or severe cases where a sizeable part of the body can have skin lesions. Now, drugmaker Almirall and digital health firm Happify are working on a tool to support mental health in these patients. Almirall is a specialist in psoriasis therapies with drugs like Skilarence (dimethyl fumarate) and Ilumetri (tildrakizumab), while Happify’s app is designed to drive away negative thoughts through

122

122

pharmaphorum

FEBRUARY 12, 2021

The life sciences industry has an important role in the Irish economy, with sectors such as biologics booming across the country. Rory Mullen, head of biopharma at Ireland’s economic development agency IDA Ireland tells pharmaphorum why business is blossoming in the Emerald Isle. With an attractive corporate tax rate and the youngest workforce in the EU, Ireland continues to be a popular destination for life science companies to settle.

Packaging 122

Packaging Pharmaceutical Companies Pharmaceutical Companies 122

pharmaphorum

FEBRUARY 9, 2021

The UK government’s massive spending on the coronavirus pandemic response has been “rife with conflicts of interest”, says the opposition Labour Party, and an independent watchdog should be set up to oversee procurement contracts. That was the message delivered by shadow Cabinet Office minister Rachel Reeves in a speech yesterday which claimed almost £2 billion of the £23.1 billion public sector spend on the pandemic went on contracts that were awarded to “Conservative friends and donors”

121

121

pharmaphorum

FEBRUARY 22, 2021

As part of our Patients Insights series, the founder and CEO of Motherhood Understood shares her experience of postpartum depression, talks about the power of peer support, and explains what the wider healthcare community could do to play their part. Within days of giving birth to her first child, Jen Schwartz’s fairy tale view of motherhood lay in tatters at the foot of the bed she found it impossible to leave.

Hospitals 120

Hospitals 120

pharmaphorum

FEBRUARY 16, 2021

Medical charity Alzheimer’s Research UK has teamed up with artificial intelligence specialist Exscientia to find new drug treatments for the devastating neurodegenerative disease. . The alliance will see Exscientia work with the charity’s Oxford Drug Discovery Institute (ODDI) to find therapeutics that target the neuroinflammation associated with Alzheimer’s disease (AD), focusing in particular on the NLRP3 inflammasome pathway.

Diabetes 117

Diabetes Immunity Immunization 117

pharmaphorum

FEBRUARY 11, 2021

Rob Wood has acquired a large minority stake in performance-io through a multimillion-pound deal that will see him join the specialist online performance marketing agency’s executive board. A former AstraZeneca director, Wood founded commercial and medical benchmarking firm STEM in 2007 before selling it to UDG Healthcare for £84 million in 2016. Since leaving that company he has invested in a number of disruptive technology-driven pharma service providers. performance-io ’s founder and CEO Matt

113

113

pharmaphorum

FEBRUARY 10, 2021

Improving the Safety, Efficacy & Predictability of Monotherapy & Combinatorial Therapies to Fast-track the Discovery & Development of TNBC Treatments to Reach Patients in Need. This is the primary industry platform specifically dedicated to providing you insight into the latest developments of safe and efficacious blockbuster therapies to treat triple negative breast cancer.

Drug Development 113

Drug Development Immunity Immunization Vaccines 113

pharmaphorum

FEBRUARY 19, 2021

Psychedelic medicine biotech MindMed is to acquire digital medicine and therapeutics startup HealthMode for around $32.2 million, which uses artificial intelligence (AI) technology to speed up drug development. The move will also see ex-Pfizer digital medicine executive Dr Daniel Karlin join the MindMed executive team, along with former Google AI guru Bradford Cross.

Drug Development 112

Drug Development 112

pharmaphorum

FEBRUARY 16, 2021

A news agency is claiming that North Korea launched a cyber-attack on Pfizer in a bid to steal information about its BioNTech-partnered COVID-19 vaccine, citing South Korea’s National Intelligence Service (NIS). The Yonhap agency said the revelation was made during a closed-door meeting of the intelligence committee of South Korea’s National Assembly.

Vaccines 109

Vaccines Hospitals 109

pharmaphorum

FEBRUARY 1, 2021

The diplomatic row that broke out last week over the supply of AstraZeneca’s vaccine to Europe appears to have cooled after the UK pharma agreed to supply an extra nine million doses. At the end of last week, the European Commission was forced into an embarrassing U-Turn when it tried to impose restrictions on COVID-19 vaccines exported from the bloc.

Vaccines 108

Vaccines 108

pharmaphorum

FEBRUARY 10, 2021

Don’t panic – that’s the message from one ABPI code expert who tells Amanda Barrell it’s time to take stock and prioritise. Compliance managers have less than six months to rewrite processes and procedures in line with the updated ABPI code of practice before it becomes enforceable in July. But it doesn’t all have to be done at once, says Dr Rina Newton, managing director at code consultancy firm, CompliMed.

Documentation 107

Documentation Pharmaceutical Companies Pharmaceutical Companies 107

pharmaphorum

FEBRUARY 3, 2021

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2 billion in 2018, according to the latest BioIndustry Association (BIA) and Clarivate report, and represents a 1,000% increase on 2012.

Vaccines 107

Vaccines Drug Development 107